MCSS functionality maps for a flexible protein

Proteins: Structure, Function and Genetics

Volumn 37, Issue 4, 1999, Pages 512-529

  Stultz, Collin M ^a,b   Karplus, Martin ^a,c  

^a HARVARD UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

HIV 1 protease; LES; Ligand design; MCSS; Protein flexibility

Indexed keywords

FUNCTIONAL GROUP; LIGAND; METHANOL; PROTEINASE; VIRUS PROTEIN;

ARTICLE; BINDING SITE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032749096     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(19991201)37:4<512::AID-PROT3>3.0.CO;2-O     Document Type: Article

References (43)

1. Miller MD, Sheridan RP, Kearsley SK, Underwood DJ. Advances in automated docking applied to human immunodeficiency virus type 1. In: Kuo LC, Shafer JA, editors. Retroviral proteases, Methods in enzymology, Vol. 41. San Diego: Academic Press; 1994:38-54.
2. Condra J, Schlef WA, Blahy OM et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 1995;374: 569-571.
3. Weichsel A, Montfrot W. Ligand-induced distortion of an active site in thymidylate synthase upon binding anticancer drug 1843U89. Nat Struct Biol 1995; 2:1095-1101.
4. Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol 1996;3:927-933.
5. Fless GM, Furbee J Jr., Snyder ML, Meredith SC. Ligand-induced conformational change of lipoprotein(a). Biochemistry 1996;35: 2289-2298.
6. Cao Y, Musah R, Wilcox S, Goodin D, McRee D. Protein conformer selection by ligand binding observed with crystallography. Protein Sci 1998;7:72-78.
7. Appelt K. Crystal structures of HIV-1 protease-inhibitor complexes. Perspect Drug Discovery Design 1993;1:23-48.
8. Auzat I, Gawlita E, Garel J. Slow ligand-induced transitions in the allosteric phosphofructokinase from Escherichia coli. J Mol Biol 1995;249:478-492.
9. Bystroff C, Kraut J. Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding. Biochemistry 1991;30:2227-2239.
10. Tong L, Pav S, Suet M, Lamarre D, Yoakim C, Beaulieu P, Anderson P. Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere. Structure 1995;3:33-40.
11. Fenton WA, Furtak K, Horwich AL. Residues in chaperonin GroEL required for polypeptide binding and release. Nature 1994;371:614-619.
12. Braig K, Otwinowski Z, Hedge R, et al. The crystal structure of bacterial chaperonin GroEL at 2.8 Å. Nature 1994;371:578-586.
13. Miranker A, Karplus M. Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins 1991;11: 29-34.
14. Kohl NE, Emini EA, Scheif WA, et al. Active immunodeficiency virus protease is required for virus infectivity. Proc Natl Acad Sci USA 1988;85:4686-4690.
15. Rutenber E, Fauman E, Keenan R, et al. Structure of a nonpeptide inhibitor complexed with HIV-1 protease J Biol Chem 1993;268:15343-15346.
16. Rose RB, Craik CS, Stroud RM. Domain flexibility in retroviral proteases: structural implications for drug resistant mutations. Biochemistry 1998;37:2607-2621.
17. Elber R, Karplus M. Enhanced sampling in molecular dynamics: use of the time-dependent hartree approximation for a simulation of carbon monoxide diffusion through myoglobin. J Am Chem Soc 1990;112:9161-9175.
18. Brooks CL, Karplus M, Pettitt BM. Proteins, a theoretical perspective of dynamics, structure, and thermodynamics. Advances in Chemical Physics, Vol. LXXI; 1988.
19. Venable RM, Brooks B, Carson FW. Theoretical studies of relaxation of a monomeric subunit of HIV-1 protease in water using molecular dynamics. Proteins 1993;15:374-384.
20. Eisen MB, Wiley DC, Karplus M, Hubbard RE. HOOK: A program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 1994;19:199-221.
21. Miranker A, Karplus M. An automated method for dynamic ligand design. Proteins 1995;23:472-490.
22. Stultz CM, Karplus M. Dynamic ligand design and combinatorial optimization: application to endothiapepsin. Proteins 2000: in press.
23. Abola EE, Bernstein FC, Bryant SH, Koetzle TF, Weng J. Protein data bank. In: Allen FH, Bergerhoff G, Sievers R, editors. Crystallographic databases - information content, software systems, scientific applications. Bonn/Cambridge, Chester: Data Commission of the International Union of Crystallography; 1987. p 107-132.
24. Bernstein FC, Koetzle TF, Williams GJB, et al. The protein data bank: a computer-based archival file for macromolecular structures. J Mol Biol 1977;112:535-542.
25. Gilson MK, Honig B. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies and conformational analysis. Proteins 1988;4:7-18.
26. Warshel A, Papazyan A. Electrostatic effects in macromolecules: fundamental concepts and practical modeling Curr Opin Struct Biol 1998;8:211-217.
27. Schaefer M, Karplus M. A comprehensive analytical treatment of continuum electrostatics. J Physical Chem 1996;100:1578-1599.
28. Swain AL, Miller MM, Green J, et al. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. Proc Nat Acad Sci USA 1990;87:8805-8809.
29. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: A program for macromolecular energy minimization and dynamics calculations. J Comp Chem 1983;4: 187-217.
30. Smith R, Brereton IM, Chai RY, Kent SB. Ionization states of the catalytic residues in HIV-1 protease. Nat Struct Biol 1996;11:946-950.
31. Yamazaki T, Linda LK, Torchia DA, et al. NMR and X-ray evidence that the HIV protease catalytic aspartyl groups are protonated in the complex formed by the protease and a nonpeptide cyclic urea based inhibitor. J Am Chem Soc 1994;116: 10791-10792.
32. Sommer M. Electrostatic modeling of biological macromolecules in solution. PhD Thesis, Harvard University, 1996.
33. Brunger AT, Karplus M. Polar hydrogen positions in proteins: empirical energy placement and neutron diffraction comparison. Proteins 1988;4:148-156.
34. Brooks C, Karplus M. Solvent effects on protein motion and protein effects on solvent motion. Dynamics of the active site of lysozyme. J Mol Biol 1989;208:159-181.
35. Van Gunsteren WF, Berendsen HJC. Algorithms for macromolecular dynamics and constraint dynamics. Mol Phys 1977;34:1311-1327.
36. Straub JE, Karplus M. Energy equipartitioning in the classical time-dependent hartree approximation. J Chem Phys 1991;94: 6737-6739.
37. Ulitsky A, Elber R. The thermal equilibrium aspects of the time-dependent-Hartree and the locally enhanced sampling approximations: formal properties, a correction, and computational examples for rare gas clusters J Chem Phys 1993;98:3380-3388.
38. Stultz CM, Karplus M. Thermal equilibrium and conformational sampling in the Locally Enhanced Sampling approximation. In press.
39. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys 1984;81:3684-3690.
40. Roitberg A, Elber R. Modeling side chains in peptides and proteins: applications of the locally enhanced sampling and the simulated annealing methods to finding minimum energy conformations. J Chem Phys 1992;95:9277-9287.
41. Stultz CM, Karplus M. On the potential surface of the locally enhanced sampling approximation. J Chem Phys 1998;109:8809-8815.
42. Caflisch A, Miranker A, Karplus M. Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase. J Med Chem 1993;36:2142-2167.
43. McCarthy DJ, Hogle JM, Karplus M. Use of the multiple copy simultaneous search (MCSS) method to design a new class of picornavirus capsid binding drugs. Proteins 1997;29:32-58.